6th Edition of Neurology World Conference 2026

Scientific Committee

Peng Xu, Neurology World Conference,Miami,USA

Peng Xu

Peng Xu

  • Designation: Drug Intelligence and Forensic Center Ministry of Public Security National Narcotics Laboratory
  • Country: China

Biography

Dr. Peng Xu is the head of the Drug Analysis Division III of the Drug Intelligence and Forensic Center, Ministry of Public Security of China, deputy director of the Key Laboratory of Drug Monitoring and Control, Ministry of Public Security. She is a member of the Expert Committee on Controlled Narcotics and Psychotropic Substances for Non-Medical Use of China and serves on a number of national expert committees and academic societies in the fields of psychotropic substances and pharmacology. Dr. Peng Xu is a recipient of the Special Government Allowance from the State Council of China and the 4th National Innovation Pioneer Award. She has received the Outstanding Contribution Award for National Narcotics Control Research Talents, the Second Prize of the National Award for Science and Technology Progress, as well as multiple first and second prizes of the Science and Technology Award of the Ministry of Public Security. Currently, Dr. Peng Xu's research mainly focus on the assessment of abuse risk of drugs and NPS.

Abstract

A standardized national drug laboratory system has been constructed within the narcotics control framework of China's Ministry of Public Security. Centered on the Drug Intelligence and Forensic Center, Ministry of Public Security and supported by five regional branch narcotics laboratories, this platform is responsible for nationwide drug situation monitoring and early warning, forensic identification of drug-related cases, abuse risk assessment of new psychoactive substances (NPS), narcotics control technology innovation, serving as the fundamental technical guarantee for national scientific drug control. A complete technical system for NPS abuse risk assessment has been established relying on the national laboratory platform. Focusing on two core evaluation indicators including NPS addiction potential and harmful effects, this system adopts dual standardized evaluation approaches: in vitro screening and in vivo functional assessment. It forms a normalized and operable assessment paradigm that supports accurate addiction and harm identification and hierarchical risk classification of various emerging NPS. Long-term basic research and frontier practical verification have yielded abundant academic achievements and typical application cases. Continuous technological breakthroughs further optimize the practicability and accuracy of the assessment system. This framework has promising application and dissemination value, and provides effective technical references from China for global NPS risk management and addiction prevention.